Ainos, Inc. (AIMD) Stock

Ainos, Inc. (AIMD) is a Technology stock trading at $1.41 (as of 2026-08-20), with a market capitalization of $12.02M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Ainos, Inc. develops medical technologies for point-of-care testing and treatment approaches. Its offerings include COVID-19 antigen rapid test kits and a cloud-based test management application, COVID-19 nucleic acid testing, volatile organic compound point-of-care testing, and oral interferon alpha formulations, with additional synthetic RNA technology activities in Taiwan.

Understand Ainos, Inc.: how it makes money

Ainos, Inc. develops medical technologies for point-of-care testing and treatment for disease indications, including COVID-19 antigen and nucleic acid tests, volatile organic compounds point-of-care testing, a cloud-based test management app, and Very Low-Dose Oral Interferon Alpha.

Its offerings combine point-of-care diagnostic tests and a cloud-based test management application, so profitability is driven by whether those products and the app generate enough revenue to cover operating costs.

Business quality (Weak): Product scope is clear from the provided description, but no reportable segments, operating KPIs, or peer comparables are provided, limiting the ability to benchmark performance drivers.

Bull case

  • Product and platform breadth: The company offers multiple testing modalities (COVID-19 antigen, COVID-19 nucleic acid, and volatile organic compounds point-of-care testing) along with a cloud-based test management app.
  • Point-of-care focus: Its stated focus is developing medical technologies for point-of-care testing and medical treatment for disease indications.

Bear case

  • No reported revenue in the provided quarter: For 2026-03-31, revenue_b is 0.0B in the provided facts.
  • Profits were deeply negative: For 2026-03-31, gross_margin_pct was -373.9 and operating_margin_pct was -1418414.3, indicating severe losses versus revenue in the provided data.
Valuation — source: SEC EDGAR (first-party)
Price$1.41
Market Cap$12.02M
Price / Book3.66
Price / Sales883.79
FCF Yield-37.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$124157.00
Net Margin-11897.0%
Revenue Growth (YoY)-96.7%
EPS Growth (YoY)-37.4%
FCF Growth (YoY)8.3%
Financial Health — source: SEC EDGAR
Altman Z-Score-6.27 (distress)
Valuation vs Sector & Industry
Sector P/E (Technology)33.9
Industry P/E (Computers)32.1
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderRENAISSANCE TECHNOLOGIES LLC ($108732.00)
Institutional Holders Tracked10
Company
SectorTechnology
IndustryComputers
CEOChun-Hsien Tsai
Employees44
CountryUS
IPO Date2021-01-08

Related Companies (Business model: Consumer Hardware (incl. ecosystem services); 8 closest by market cap; US-domiciled)

  • Immersion Corporation (IMMR)
  • AstroNova, Inc. (ALOT)
  • Interlink Electronics, Inc. (LINK)
  • Identiv, Inc. (INVE)
  • TransAct Technologies Incorporated (TACT)
  • Virtuix Holdings Inc. Class A Common Stock (VTIX)
  • Socket Mobile, Inc. (SCKT)
  • Emerson Radio Corp. (MSN)
AIMD earnings history · AIMD institutional & insider holders · AIMD KPIs & operating metrics · AIMD financials · AIMD investor presentations & press releases · AIMD SEC filings · AIMD peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.